News

Filter

Current filters:

Gentium

Jazz Pharma and Gentium debut Defitelio in Europe

31-03-2014

Ireland-headquartered Jazz Pharmaceuticals and its Italian subsidiary Gentium have initiated the European…

AustriaDefitelioEuropeGentiumGermanyJazz PharmaceuticalsMarkets & MarketingPharmaceuticalRare diseases

PharmaSwiss to distribute Gentium's defibrotide in CEE and other countries

03-05-2012

Italian drugmaker Gentium SpA (Nasdaq: GENT) has appointed PharmaSwiss, a division of Canada's Valeant…

defibrotideEuropeGentiumLicensingNephrology and HepatologyPharmaceuticalPharmaSwissValeant Pharmaceuticals

Gentium withdraws US NDA for defibrotide

19-08-2011

Italian drug developer Gentium SpA (Nasdaq: GENT) saw its shares price plunge 29% to $6.22 on the Nasdaq…

Cardio-vasculardefibrotideGentiumNorth AmericaPharmaceuticalRegulationSigma Tau

COMPANY SPOTLIGHT

Menarini

Back to top